Aubhishek Zaman, PhD

Title(s)Postdoctoral Scholar, Medicine
SchoolSchool of Medicine
Address600 16th St
San Francisco CA 94158
Phone415-502-0237
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Targeting AXL in NSCLC. Lung Cancer (Auckl). 2021; 12:67-79. Zaman A, Bivona TG. PMID: 34408519; PMCID: PMC8364399.
      View in: PubMed   Mentions:
    2. Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote virus detection and cancer. Cell Rep. 2021 08 03; 36(5):109491. Zaman A, Wu X, Lemoff A, Yadavalli S, Lee J, Wang C, Cooper J, McMillan EA, Yeaman C, Mirzaei H, White MA, Bivona TG. PMID: 34348154; PMCID: PMC8383154.
      View in: PubMed   Mentions:    Fields:    
    3. Long non-coding RNA ESCCAL-1 promotes esophageal squamous cell carcinoma by down regulating the negative regulator of APOBEC3G. Cancer Lett. 2020 11 28; 493:217-227. Liu J, Mayekar MK, Wu W, Yan M, Guan H, Wang J, Zaman A, Cui Y, Bivona TG, Choudhry H, Xing Q, Cao W. PMID: 32905814.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    4. Multi-faceted epigenetic dysregulation of gene expression promotes esophageal squamous cell carcinoma. Nat Commun. 2020 07 22; 11(1):3675. Cao W, Lee H, Wu W, Zaman A, McCorkle S, Yan M, Chen J, Xing Q, Sinnott-Armstrong N, Xu H, Sailani MR, Tang W, Cui Y, Liu J, Guan H, Lv P, Sun X, Sun L, Han P, Lou Y, Chang J, Wang J, Gao Y, Guo J, Schenk G, Shain AH, Biddle FG, Collisson E, Snyder M, Bivona TG. PMID: 32699215; PMCID: PMC7376194.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    5. Targeting Oncogenic BRAF: Past, Present, and Future. Cancers (Basel). 2019 Aug 16; 11(8). Zaman A, Wu W, Bivona TG. PMID: 31426419; PMCID: PMC6721448.
      View in: PubMed   Mentions: 29  
    6. RAS nucleotide cycling underlies the SHP2 phosphatase dependence of mutant BRAF-, NF1- and RAS-driven cancers. Nat Cell Biol. 2018 09; 20(9):1064-1073. Nichols RJ, Haderk F, Stahlhut C, Schulze CJ, Hemmati G, Wildes D, Tzitzilonis C, Mordec K, Marquez A, Romero J, Hsieh T, Zaman A, Olivas V, McCoach C, Blakely CM, Wang Z, Kiss G, Koltun ES, Gill AL, Singh M, Goldsmith MA, Smith JAM, Bivona TG. PMID: 30104724; PMCID: PMC6115280.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    7. Emerging application of genomics-guided therapeutics in personalized lung cancer treatment. Ann Transl Med. 2018 May; 6(9):160. Zaman A, Bivona TG. PMID: 29911108; PMCID: PMC5985272.
      View in: PubMed   Mentions: 10  
    8. TBK1 Provides Context-Selective Support of the Activated AKT/mTOR Pathway in Lung Cancer. Cancer Res. 2017 09 15; 77(18):5077-5094. Cooper JM, Ou YH, McMillan EA, Vaden RM, Zaman A, Bodemann BO, Makkar G, Posner BA, White MA. PMID: 28716898; PMCID: PMC5833933.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCells
    9. Biomarker Accessible and Chemically Addressable Mechanistic Subtypes of BRAF Melanoma. Cancer Discov. 2017 08; 7(8):832-851. Eskiocak B, McMillan EA, Mendiratta S, Kollipara RK, Zhang H, Humphries CG, Wang C, Garcia-Rodriguez J, Ding M, Zaman A, Rosales TI, Eskiocak U, Smith MP, Sudderth J, Komurov K, Deberardinis RJ, Wellbrock C, Davies MA, Wargo JA, Yu Y, De Brabander JK, Williams NS, Chin L, Rizos H, Long GV, Kittler R, White MA. PMID: 28455392; PMCID: PMC5540806.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    10. Role of the Exocyst Complex Component Sec6/8 in Genomic Stability. Mol Cell Biol. 2015 Nov; 35(21):3633-45. Torres MJ, Pandita RK, Kulak O, Kumar R, Formstecher E, Horikoshi N, Mujoo K, Hunt CR, Zhao Y, Lum L, Zaman A, Yeaman C, White MA, Pandita TK. PMID: 26283729; PMCID: PMC4589602.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    Aubhishek's Networks
    Concepts (93)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (5)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB01.

    Copyright © The Regents of the University of California